Prognosic Factors Related to The Complete Hematologic Response (CHR) in 3 Months in Leukemia Granulositic Patients Administered with Imatinib Mesylate
Introduction. The complete hematologic response is an integral part to achieve the complete cytogenetic response target and the major molecular response of imatinib mesylate therapy, although it does not determine the prognosis. The complete hematologic response in Indonesia is lower than in the wor...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Indonésio |
| Publicat: |
Department of Internal Medicine, Faculty of Medicine Universitas Indonesia
2020-09-01
|
| Col·lecció: | Jurnal Penyakit Dalam Indonesia |
| Matèries: | |
| Accés en línia: | http://jurnalpenyakitdalam.ui.ac.id/index.php/jpdi/article/view/461/245 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|